Skip to content

Vinayak Singh

  • PhD
  • PDRF
  • Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
  • 7h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 116CitationsNumber of citations received by Vinayak's publications. Updated daily.

Other IDs

About

Currently, I am working in the field of anti-tubercular drug-discovery.

Co-authors (114)

Publications (5)

  • Genome-Wide Transposon Mutagenesis in Mycobacterium tuberculosis and Mycobacterium smegmatis

    • Majumdar G
    • Mbau R
    • Singh V
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Identification and validation of novel drug targets in Mycobacterium tuberculosis

    • Singh V
    • Mizrahi V
    N/AReaders
    N/ACitations
    Get full text
  • Identification of Aminopyrimidine-Sulfonamides as Potent Modulators of Wag31-mediated Cell Elongation in Mycobacteria.

    • Singh V
    • Dhar N
    • Pató J
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Real-Time Investigation of Tuberculosis Transmission: Developing the Respiratory Aerosol Sampling Chamber (RASC)

    • Wood R
    • Morrow C
    • Barry C
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis

    • Singh V
    • Donini S
    • Pacitto A
    • et al.
    N/AReaders
    N/ACitations
    Get full text

Professional experience

PDRF

Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa

May 2011 - Present